文献速递青光眼眼底病与葡萄膜炎

MYOC p.Gln368Ter变异特征及多基因风险对UK Biobank青光眼外显率的影响

Characteristics of p.Gln368Ter Myocilin Variant and Influence of Polygenic Risk on Glaucoma Penetrance in the UK Biobank.
PubMed 文献 · Ophthalmology · 2021-03-10

45人(25.4%)至少一眼有 probable/definite 青光眼,19人(10.7%)双眼青光眼,69%未诊断;POAG多基因风险评分(PRS)升高与DDG患病率及既往诊断相关。

要点

  • MYOC p.Gln368Ter携带者中25.4%至少一眼有 probable/definite 青光眼,10.7%双眼受累。
  • 有 disc-defined glaucoma(DDG)者中69%未诊断,31%有自报或ICD编码青光眼。
  • 多数携带者眼压正常(≤21 mmHg),但DDG及既往诊断者该比例更低。

核心结论

  • MYOC p.Gln368Ter变异携带者中约四分之一有青光眼证据,外显率高于既往估计,且69%病例未被诊断。
  • 多数携带者包括DDG者眼压处于正常范围,POAG PRS升高与疾病外显率和严重程度增加相关。

研究设计与样本

  • 计算全基因组POAG PRS,由2名设盲分级者 review 眼底照片判定 disc-defined glaucoma(DDG)。

主要发现

  • DDG者中31%自报或有ICD编码青光眼,69%未诊断。
  • DDG者 medication-adjusted cornea-corrected intraocular pressure(IOPcc)高于无青光眼者(P < 0.001),既往诊断者与未诊断者间差异更大(P < 0.001)。
  • 多数p.Gln368Ter携带者IOP≤21 mmHg,但DDG者(P < 0.02)及既往诊断者(P < 0.03)该比例更低。
  • DDG者PRS显著高于无青光眼者(0.37 ± 0.97 vs. 0.01 ± 0.90;P = 0.03);DDG中既往诊断者PRS高于未诊断者(1.31 ± 0.64 vs. 0.00 ± 0.81;P < 0.001),且处于PRS最高十分位的校正优势比为27.5(95%CI 2.5-306.6)。

关键数值与推荐

  • POAG PRS每增加一个十分位,DDG患病率增加。
  • DDG中既往诊断者处于PRS最高十分位的校正OR为27.5(95%CI 2.5-306.6)。

临床怎么用

  • 对MYOC p.Gln368Ter携带者应进行眼底视盘评估,不应仅依赖眼压筛查,因多数携带者眼压正常。
  • POAG PRS可用于MYOC p.Gln368Ter携带者的风险分层,识别更高外显率和更严重疾病风险个体。

局限性

  • 横断面设计无法确定因果关系或纵向外显率。
  • 仅纳入有眼底照片的UK Biobank参与者,可能存在选择偏倚。
  • DDG由2名分级者基于眼底照片判定,未报告分级一致性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: MYOC (myocilin) mutations account for 3% to 5% of primary open-angle glaucoma (POAG) cases. We aimed to understand the true population-wide penetrance and characteristics of glaucoma among individuals with the most common MYOC variant (p.Gln368Ter) and the impact of a POAG polygenic risk score (PRS) in this population. DESIGN: Cross-sectional population-based study. PARTICIPANTS: Individuals with the p.Gln368Ter variant among 77 959 UK Biobank participants with fundus photographs (FPs). METHODS: A genome-wide POAG PRS was computed, and 2 masked graders reviewed FPs for disc-defined glaucoma (DDG). MAIN OUTCOME MEASURES: Penetrance of glaucoma. RESULTS: Two hundred individuals carried the p.Gln368Ter heterozygous genotype, and 177 had gradable FPs. One hundred thirty-two showed no evidence of glaucoma, 45 (25.4%) had probable/definite glaucoma in at least 1 eye, and 19 (10.7%) had bilateral glaucoma. No differences were found in age, race/ethnicity, or gender among groups (P > 0.05). Of those with DDG, 31% self-reported or had International Classification of Diseases codes for glaucoma, whereas 69% were undiagnosed. Those with DDG had higher medication-adjusted cornea-corrected intraocular pressure (IOPcc) (P < 0.001) vs. those without glaucoma. This difference in IOPcc was larger in those with DDG with a prior glaucoma diagnosis versus those not diagnosed (P < 0.001). Most p.Gln368Ter carriers showed IOP in the normal range (≤21 mmHg), although this proportion was lower in those with DDG (P < 0.02) and those with prior glaucoma diagnosis (P < 0.03). Prevalence of DDG increased with each decile of POAG PRS. Individuals with DDG demonstrated significantly higher PRS compared with those without glaucoma (0.37 ± 0.97 vs. 0.01 ± 0.90; P = 0.03). Of those with DDG, individuals with a prior diagnosis of glaucoma had higher PRS compared with undiagnosed individuals (1.31 ± 0.64 vs. 0.00 ± 0.81; P < 0.001) and 27.5 times (95% confidence interval, 2.5-306.6) adjusted odds of being in the top decile of PRS for POAG. CONCLUSIONS: One in 4 individuals with the MYOC p.Gln368Ter mutation demonstrated evidence of glaucoma, a substantially higher penetrance than previously estimated, with 69% of cases undetected. A large portion of p.Gln368Ter carriers, including those with DDG, have IOP in the normal range, despite similar age. Polygenic risk score increases disease penetrance and severity, supporting the usefulness of PRS in risk stratification among MYOC p.Gln368Ter carriers.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Zebardast N, Sekimitsu S, Wang J, et al. Characteristics of p.Gln368Ter Myocilin Variant and Influence of Polygenic Risk on Glaucoma Penetrance in the UK Biobank. Ophthalmology. 2021. PMID: 33713785. doi:10.1016/j.ophtha.2021.03.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。